Alzheimer’s trials face the unique challenge of studying participants with cognitive decline, amid a move towards digital ...

The ASUNCTIS trial evaluated asunercept's safety and efficacy in COVID-19, showing trends toward faster recovery despite not ...

Before propensity matching, mothers of tetracycline-exposed infants were more often in the youngest and oldest age strata and ...

X4 Pharmaceuticals Announces Positive Results from Completed Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN) ...